🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522468-34-00
Completed Phase I

Phase I clinical trial evaluating the safety, tolerability, and absorption of a topical product containing latanoprost acid in healthy participants.

2025-522468-34-00 · tracked via the Priya Life Science EU tracker
Sponsor
Bioresearch Pharma S.A.
Sponsor type
Pharmaceutical company
Therapeutic area
Skin and Connective Tissue Diseases
Decision date
29/04/2026
Enrollment target
24
Sites
Poland

Condition studied

Androgenetic alopecia

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522468-34-00 on CTIS ↗ ← All trials in the EU